Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BY 4.0Biochemical Society Transactions

Molecular determinants of α-synuclein toxicity and aggregation revealed by deep mutagenesis

  1. 1Department of Chemistry, The University of Texas at Austin, 105 E 24th St. Austin, TX, 78712, U.S.A.

Abstract

The abundant neuronal protein α-synuclein is a key driver of Parkinson’s and related diseases. α-Synuclein adopts a wide variety of different conformational states, but it is often unclear which of these species is responsible for its various behaviors, complicating efforts to combat pathologic misfolding of α-synuclein. Whereas conventional approaches struggle to provide direct, high-resolution insight into these structure–activity relationships, deep mutational scanning (DMS) has recently emerged as a powerful approach to probe the structural basis of protein activity and identify the molecular determinants of pathology. In the present review, we highlight insights from recent DMS studies of α-synuclein, which have implicated membrane binding as an important contribution to its toxicity and aggregation. Further, experiments in different cell types reveal distinct determinants of aggregation, highlighting the role of the cellular environment in shaping the conformational landscape of α-synuclein. We therefore expect that DMS will fill an important gap in the characterization of protein structure–activity relationships, particularly for conformationally dynamic proteins, including those implicated in misfolding diseases.

Related

  1. A Computational Investigation of Curcumin Glucoside in α-Synuclein Aggregation: DFT Characterization, Molecular Docking, and Secondary Data Analysis
    Lakshmi Sowmya Emani, Pranathi Jalapally, Gerardo Samudio-Ríos +4
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  2. Artificial Intelligence in Drug-Safety and Toxicity Assessment: Molecular Determinants and Bridging Preclinical Signals to Patient Safety
    Divya Jyothi Madipally, Janna Pathi, Maci M. Burgener +1
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  3. Aβ42-Driven α-synuclein Fibril Polymorphism and Distinct Intracellular Aggregation
    Purnopama Saha, Teshani Liyanaarachchige, Anika Alim +2
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationPMCbioRxiv
  4. Examining the Atypical Structure Adopted by the 37-51 Segment of α-synuclein in the Early Stage of Aggregation
    A. Guzzo, P. Delarue, K. Kachlishvili +3
    bioRxivPreprintAll rights reservedFull textBiophysicsbioRxiv
  5. Peptidomimetics Inspired by α-Synuclein or Its Chaperone αB-Crystallin Differentially Modulate α-Synuclein Aggregation
    Nicolo Bisi, Josine Kothuis, Julia Kaffy +14
    Journal of Medicinal ChemistryPeer-reviewedCC BY 4.0Full text1 citedBiophysicsStructural biologyHAL
BibTeX
@article{noh2026molecular,
  title = {{Molecular determinants of α-synuclein toxicity and aggregation revealed by deep mutagenesis}},
  author = {Daeun Noh and Robert W. Newberry},
  journal = {Biochemical Society Transactions},
  year = {2026},
  month = nov,
  doi = {10.1042/bst20250295},
  url = {https://doi.org/10.1042/bst20250295},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Molecular determinants of α-synuclein toxicity and aggregation revealed by deep mutagenesis
AU  - Daeun Noh
AU  - Robert W. Newberry
PY  - 2026
DA  - 2026/11/03
JO  - Biochemical Society Transactions
DO  - 10.1042/bst20250295
UR  - https://doi.org/10.1042/bst20250295
AB  - The abundant neuronal protein α-synuclein is a key driver of Parkinson’s and related diseases. α-Synuclein adopts a wide variety of different conformational states, but it is often unclear which of these species is responsible for its various behaviors, complicating efforts to combat pathologic misfolding of α-synuclein. Whereas conventional approaches struggle to provide direct, high-resolution insight into these structure–activity relationships, deep mutational scanning (DMS) has recently emerged as a powerful approach to probe the structural basis of protein activity and identify the molecular determinants of pathology. In the present review, we highlight insights from recent DMS studies of α-synuclein, which have implicated membrane binding as an important contribution to its toxicity and aggregation. Further, experiments in different cell types reveal distinct determinants of aggregation, highlighting the role of the cellular environment in shaping the conformational landscape of α-synuclein. We therefore expect that DMS will fill an important gap in the characterization of protein structure–activity relationships, particularly for conformationally dynamic proteins, including those implicated in misfolding diseases.
SN  - 0300-5127
SN  - 1470-8752
ER  -